$PROG

For trade details click on this link to the trades   PROGENITY Inc up 38.05%  COO Silvestry bought 58,081 shares of PROG at $4.58.  Progenity announced on December 17th  that it is expanding the availability of COVID-19 RT-PCR testing across the United States to support the rising demand for testing. Testing is performed using the Thermo Fisher Applied Biosystems TaqPath COVID-19 Combo Kit, under Emergency Use Authorization by the FDA. Although the stock rocketed on this news combined with insider buying, it’s been a rough haul for shareholders.  Give this one a little time to pullback. PROG recently did a … Read more